Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex for Macular Edema in Retinal Vein Occlusion (GENEVA)
NCT00168298Phase 3Completed
- Sponsor
- Allergan
- Start
- Nov 2004
- Primary completion
- Mar 2008
- Modality
- Orthosteric Ligands
- Countries
- 13
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in macular edema (3 arms), sponsored by Allergan. Primary endpoint: Number of Patients With 15 or More Letter Improvement in Best Corrected Visual Acuity (BCVA) in the Study Eye at Day 180. Started Nov 2004; status: completed.
02
Drugs
dexamethasone
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT00168298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168298.